mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Cross posted from https://slrpnk.net/post/41680206